Mohammad Farag

Dr. Mohammad Farag

orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Materials Science
Verified
Journal Article
Open access
PDF file
MFMohammad Farag
Mohammad Farag
Tissue engineering is approach of replacing or regeneration of biological functions of tissues or organs by using combination of biomaterials, biomolecules and cells. Tissue engineering mainly depends scaffold biomaterials and scaffold fabrication methods. Therefore, there have been progressive investigation and development of new biomaterials with different formulations to help and achieve necessary requirements in the tissue engineering applications. This review is briefly representing necessary features associated with biomaterial type and design required for tissue regeneration applications, and presenting earlier research in tissue engineering field and new trends for future implementation. It is mainly focusing on generations of biomaterials and discovery tissue engineering field. As well as, different types of biomaterials, such as bioceramics, bioactive glasses, synthetic and natural polymers and their derived composites, used in fabrication of scaffolds (as a main part of tissue engineering) are demonstrated in this review. Scaffold fabrication methods are also reviewed here. Moreover, it is showing the recent achievements in tissue engineering field for bone, skin, cartilage, neural, and cardiac regeneration as a pre-clinical procedure for repair of injured and diseased tissues and organs. Finally, recent trends and challenges of biomaterials for tissue regeneration are presented also in this review.Graphical abstract

1 October 2014 in Materials Letters
Verified
Journal Article
Closed access
MFMohammad Farag
Mohammad Farag
HYHui-Suk Yun
Hui-Suk Yun

1 March 2014 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JLJongman Lee
Jongman Lee
MFMohammad Farag
Mohammad Farag
EPEui Kyun Park
Eui Kyun Park
JLJiwon Lim
Jiwon Lim
HYHui-suk Yun
Hui-suk Yun

1 January 2010 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
AEAbeer M. El-Kady
Abeer M. El-Kady
AAAshraf F. Ali
Ashraf F. Ali
MFMohammad Farag
Mohammad Farag

1 August 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AEAbeer M. El-Kady
Abeer M. El-Kady
MFMohammad Farag
Mohammad Farag
AEAhlam M.I. El-Rashedi
Ahlam M.I. El-Rashedi

1 January 2015 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
AEAbeer M. El-Kady
Abeer M. El-Kady
MFMohammad Farag
Mohammad Farag
Bioactive glass nanoparticles were synthesized and tested for the first time as a new delivery system for sustained 5‐fluorouracil (5‐FU) release. They were characterized by TEM, DTA, TGA, and FT‐IR. The porosity % and specific surface area of glass nanoparticles were 85.59% and 378.36 m2/g, respectively. The in vitro bioactivity evaluation confirmed that bioactive glass disks prepared from these nanoparticles could induce hydroxyapatite layer over their surfaces in simulated body fluid. The in vitro drug release experiment indicated that glass nanoparticles could serve as long‐term local delivery vehicles for sustained 5‐FU release. The release profile of 5‐FU showed an initial fast release stage followed by a second stage of slower release. The initial burst release of 5‐FU in the first day was about 23% (28.92 mg·L−1) of the total amount of loaded 5‐FU, while the final cumulative percentage of the 5‐FU released after 32 days was about 45.6% (57.31 mg·L−1) of the total amount of loaded 5‐FU. The application of different mathematical models indicated that 5‐FU was released by diffusion controlled mechanism and suggested that its release rate was dependent on glass particles dissolution, changes of surface area as well as diameter of glass particles, and concentration of loaded drug.